Subject Numbers and Placebo Outcome Variability in Clinical Trials of New CNS Medications

被引：0
|
作者：
Derry Ridgway
Arif Khan
Gavin Ridgway
Mark A. Cierpial
Charles G. Lineberry
机构：
[1] Constella Group,
[2] Northwest Clinical Research Center,undefined
[3] Duke University Medical Center,undefined
来源：
Drug information journal : DIJ / Drug Information Association | 2007年 / 41卷
关键词：
Placebo; Outcome variability; Funnel plot;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：701 / 708
页数：7
相关论文
共 50 条
  • [1] Subject numbers and placebo outcome variability in clinical trials of new CNS medications
    Ridgway, Derry
    Khan, Arif
    Ridgway, Gavin
    Cierpial, Mark A.
    Lineberry, Charles G.
    DRUG INFORMATION JOURNAL, 2007, 41 (06): : 701 - 708
  • [2] Risk factors for subject withdrawals in clinical trials evaluating glaucoma medications
    William C. Stewart
    Christina M. Demos
    Meredith K. Turner
    Jeanette A. Stewart
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1007 - 1012
  • [3] Risk factors for subject withdrawals in clinical trials evaluating glaucoma medications
    Stewart, William C.
    Demos, Christina M.
    Turner, Meredith K.
    Stewart, Jeanette A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (07) : 1007 - 1012
  • [4] Dopomine agonists in the future - clinical trials of new medications
    Jasinska-Myga, Barbara
    Opala, Grzegorz
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (02) : S49 - S53
  • [5] Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects
    Benedetti, Fabrizio
    Carlino, Elisa
    Piedimonte, Alessandro
    LANCET NEUROLOGY, 2016, 15 (07): : 736 - 747
  • [6] Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
    Cotter, Gad
    Davison, Beth A.
    Edwards, Christopher
    Senger, Stefanie
    Teerlink, John R.
    Zannad, Faiez
    Nielsen, Olav Wendelboe
    Metra, Marco
    Mebazaa, Alexandre
    Chioncel, Ovidiu
    Greenberg, Barry H.
    Maggioni, Aldo P.
    Ertl, Georg
    Sato, Naoki
    Cohen-Solal, Alain
    AMERICAN HEART JOURNAL, 2021, 240 : 73 - 80
  • [7] Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
    Guptill, Jeffrey T.
    Benatar, Michael
    Granit, Volkan
    Habib, Ali A.
    Howard, James F.
    Barnett-Tapia, Carolina
    Nowak, Richard J.
    Lee, Ikjae
    Ruzhansky, Katherine
    Dimachkie, Mazen M.
    Cutter, Gary R.
    Kaminski, Henry J.
    NEUROLOGY, 2023, 101 (10) : 442 - 451
  • [8] ADDRESSING OUTCOME MEASURE VARIABILITY IN MYASTHENIA GRAVIS CLINICAL TRIALS
    Guptill, Jeffrey T.
    Granit, Volkan
    Habib, Ali
    Lee, Ikjae
    Ruzhansky, Katherine
    Howard, James F., Jr.
    Barnett-Tapia, Carolina
    Dimachkie, Mazen M.
    Nowak, Richard J.
    Kaminski, Henry J.
    Benatar, Michael
    MUSCLE & NERVE, 2022, 65 : S11 - S12
  • [9] Placebo controls in clinical trials of new therapies for osteoporosis
    Levine, RJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 1154 - 1159
  • [10] Outcome measures and serious asthma exacerbation in clinical trials of asthma controller medications
    Schilling, Joshua P.
    Khan, Shirin R. F.
    Khan, Arif
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (06) : 448 - 453
12345